Coagulation Market Research Reports & Industry Analysis
Coagulation factors have been implicated as independent factors in the development of myocardial infarction, stroke and deep vein thrombosis in some patients. With the increasing incidence of cardiovascular diseases, this discovery has brought what was a rather lackluster discipline into the limelight. The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.
Demand for rapid decentralized coagulation testing is increasing. The number of patients needing coagulation testing is growing. More patients are using anticoagulants following implantation of mechanical heart valves or after atrial fibrillation. More recently patients are using antithrombotic agents after, or to prevent, deep venous thrombosis, arterial or pulmonary embolism, stroke, angina pectoris, and myocardial infarction. There is also increasing pressure to return results to clinicians rapidly so that anticoagulant therapy can be adjusted.
Coagulation Industry Research & Market Reports
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
... policies and funding investments drive the demand for Point of Care (POC) testing in the ASEAN region. Governments in these countries are increasingly supporting adopting such technologies to improve health access, reduce costs, and enhance ... Read More
-
2025 Global: Heparin Active Pharmaceutical Ingredients Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Human Coagulation Factor Vii Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
2025 Global: Hemostasis Diagnostics Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Hemostasis Analyzers Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Hemostasis Diagnostic Devices And Equipment Global Market Report 2025
... diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Hemostasis Products
... CAGR of 3.7% over the analysis period 2024-2030. Infusible Hemostasis, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Point-of-Care (POC) Coagulation Testing Devices Global Market Report 2025
... (poc) coagulation testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Heparin
... 2.8% over the analysis period 2024-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of the ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
... the initiation of heparin therapy. It is primarily caused by the formation of antibodies against platelet factor 4 (PF4) and heparin. The diagnosis of Heparin-induced thrombocytopenia is based on a combination of clinical assessment, laboratory ... Read More
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
Coagulation / Hemostasis Analyzers
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$3.8 Billion by ... Read More
-
Hematology Instruments and Reagents
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hematology Analyzers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the ... Read More
-
Hemostasis and Tissue Sealing Agents
... Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Topical Hemostat, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$7.4 Billion ... Read More
-
2025 Global Fully Automated Coagulation Analyzer Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.2% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$8.8 Billion by the end ... Read More
-
Antithrombin
... 5.3% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth in ... Read More
-
Hemostasis Diagnostics
... CAGR of 4.8% over the analysis period 2024-2030. Prothrombin Test Time (PT), one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Plasma Fractionation
... CAGR of 5.1% over the analysis period 2024-2030. Immunoglobulins, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$14.8 Billion by the end of the analysis period. ... Read More
-
D-dimer Testing
... CAGR of 4.0% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
2025 Bangladesh Diagnostics Market Shares and Segment Forecasts 500 Tests: 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocri
... Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM The report profiles over 70 companies, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Cepheid/Danaher ... Read More
-
2025 Lebanon Diagnostics Market Shares and Segment Forecasts 500 Tests: 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine
... Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM The report profiles over 70 companies, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Cepheid/Danaher ... Read More
-
2025 Austria Diagnostics Market Shares and Segment Forecasts 500 Tests: 2024 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endoc
... Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM The report profiles over 70 companies, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Cepheid/Danaher ... Read More
-
2025 Bulgaria Diagnostics Market Shares and Segment Forecasts 500 Tests: 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for 500 Blood Banking, Cancer Diagnostic, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine
... Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics TDM The report profiles over 70 companies, including: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Cepheid/Danaher ... Read More
-
2025 Global Forecast for Heparin Active Pharmaceutical Ingredients Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
Research Assistance
